USANA HEALTH SCIENCES INC (USNA) Stock Fundamental Analysis
NYSE:USNA - New York Stock Exchange, Inc. - US90328M1071 - Common Stock
Taking everything into account, USNA scores 6 out of 10 in our fundamental rating. USNA was compared to 37 industry peers in the Personal Care Products industry. USNA has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. USNA is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year USNA was profitable.
USNA had a positive operating cash flow in the past year.
In the past 5 years USNA has always been profitable.
In the past 5 years USNA always reported a positive cash flow from operatings.
1.2 Ratios
USNA's Return On Assets of 8.09% is fine compared to the rest of the industry. USNA outperforms 77.78% of its industry peers.
The Return On Equity of USNA (10.19%) is better than 75.00% of its industry peers.
USNA has a Return On Invested Capital of 9.33%. This is in the better half of the industry: USNA outperforms 66.67% of its industry peers.
The Average Return On Invested Capital over the past 3 years for USNA is above the industry average of 13.52%.
The last Return On Invested Capital (9.33%) for USNA is well below the 3 year average (17.38%), which needs to be investigated, but indicates that USNA had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.09% | ||
| ROE | 10.19% | ||
| ROIC | 9.33% |
ROA(3y)13.96%
ROA(5y)16.16%
ROE(3y)19.43%
ROE(5y)23.02%
ROIC(3y)17.38%
ROIC(5y)19.97%
1.3 Margins
USNA's Profit Margin of 6.30% is fine compared to the rest of the industry. USNA outperforms 69.44% of its industry peers.
USNA's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 9.55%, USNA is in the better half of the industry, outperforming 63.89% of the companies in the same industry.
In the last couple of years the Operating Margin of USNA has declined.
The Gross Margin of USNA (80.86%) is better than 100.00% of its industry peers.
USNA's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.55% | ||
| PM (TTM) | 6.3% | ||
| GM | 80.86% |
OM growth 3Y-13.39%
OM growth 5Y-8.6%
PM growth 3Y-14.27%
PM growth 5Y-8.18%
GM growth 3Y-0.31%
GM growth 5Y-0.56%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so USNA is creating value.
The number of shares outstanding for USNA has been reduced compared to 1 year ago.
USNA has less shares outstanding than it did 5 years ago.
USNA has a worse debt/assets ratio than last year.
2.2 Solvency
USNA has an Altman-Z score of 6.12. This indicates that USNA is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 6.12, USNA is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
There is no outstanding debt for USNA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 6.12 |
ROIC/WACC1.01
WACC9.25%
2.3 Liquidity
A Current Ratio of 3.93 indicates that USNA has no problem at all paying its short term obligations.
With an excellent Current ratio value of 3.93, USNA belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
A Quick Ratio of 3.37 indicates that USNA has no problem at all paying its short term obligations.
USNA has a better Quick ratio (3.37) than 86.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.93 | ||
| Quick Ratio | 3.37 |
3. Growth
3.1 Past
The earnings per share for USNA have decreased by -8.41% in the last year.
USNA shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -8.37% yearly.
USNA shows a decrease in Revenue. In the last year, the revenue decreased by -7.11%.
Measured over the past years, USNA shows a decrease in Revenue. The Revenue has been decreasing by -4.98% on average per year.
EPS 1Y (TTM)-8.41%
EPS 3Y-17.42%
EPS 5Y-8.37%
EPS Q2Q%-5.08%
Revenue 1Y (TTM)-7.11%
Revenue growth 3Y-6.72%
Revenue growth 5Y-4.98%
Sales Q2Q%-6.16%
3.2 Future
USNA is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -5.97% yearly.
The Revenue is expected to grow by 3.88% on average over the next years.
EPS Next Y-24.27%
EPS Next 2Y-12.36%
EPS Next 3Y-5.97%
EPS Next 5YN/A
Revenue Next Year-6.86%
Revenue Next 2Y2.01%
Revenue Next 3Y3.88%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 12.07 indicates a correct valuation of USNA.
86.11% of the companies in the same industry are more expensive than USNA, based on the Price/Earnings ratio.
USNA's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.29.
A Price/Forward Earnings ratio of 13.48 indicates a correct valuation of USNA.
86.11% of the companies in the same industry are more expensive than USNA, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 24.44. USNA is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.07 | ||
| Fwd PE | 13.48 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, USNA is valued cheaply inside the industry as 97.22% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of USNA indicates a rather cheap valuation: USNA is cheaper than 86.11% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.92 | ||
| EV/EBITDA | 3.03 |
4.3 Compensation for Growth
The decent profitability rating of USNA may justify a higher PE ratio.
A cheap valuation may be justified as USNA's earnings are expected to decrease with -5.97% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-12.36%
EPS Next 3Y-5.97%
5. Dividend
5.1 Amount
No dividends for USNA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
USANA HEALTH SCIENCES INC
NYSE:USNA (1/22/2025, 10:42:54 AM)
34.17
-0.21 (-0.61%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners55.6%
Inst Owner Change-0.13%
Ins Owners0.39%
Ins Owner Change0%
Market Cap651.28M
Analysts43.33
Price Target47.43 (38.81%)
Short Float %4.1%
Short Ratio4.42
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.74%
Min EPS beat(2)-18.68%
Max EPS beat(2)13.2%
EPS beat(4)3
Avg EPS beat(4)20.59%
Min EPS beat(4)-18.68%
Max EPS beat(4)65.46%
EPS beat(8)6
Avg EPS beat(8)25.45%
EPS beat(12)6
Avg EPS beat(12)12.81%
EPS beat(16)9
Avg EPS beat(16)11.72%
Revenue beat(2)0
Avg Revenue beat(2)-5.09%
Min Revenue beat(2)-5.56%
Max Revenue beat(2)-4.61%
Revenue beat(4)1
Avg Revenue beat(4)-2.42%
Min Revenue beat(4)-5.56%
Max Revenue beat(4)2.05%
Revenue beat(8)4
Avg Revenue beat(8)-0.33%
Revenue beat(12)5
Avg Revenue beat(12)-1.33%
Revenue beat(16)8
Avg Revenue beat(16)-0.73%
PT rev (1m)0%
PT rev (3m)-3.12%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-30.07%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.8%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.03%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.46%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.07 | ||
| Fwd PE | 13.48 | ||
| P/S | 0.76 | ||
| P/FCF | 9.92 | ||
| P/OCF | 8.02 | ||
| P/B | 1.22 | ||
| P/tB | 1.34 | ||
| EV/EBITDA | 3.03 |
EPS(TTM)2.83
EY8.28%
EPS(NY)2.53
Fwd EY7.42%
FCF(TTM)3.45
FCFY10.09%
OCF(TTM)4.26
OCFY12.48%
SpS45.22
BVpS27.97
TBVpS25.53
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.09% | ||
| ROE | 10.19% | ||
| ROCE | 14.79% | ||
| ROIC | 9.33% | ||
| ROICexc | 27.08% | ||
| ROICexgc | 35.74% | ||
| OM | 9.55% | ||
| PM (TTM) | 6.3% | ||
| GM | 80.86% | ||
| FCFM | 7.62% |
ROA(3y)13.96%
ROA(5y)16.16%
ROE(3y)19.43%
ROE(5y)23.02%
ROIC(3y)17.38%
ROIC(5y)19.97%
ROICexc(3y)44.61%
ROICexc(5y)53.22%
ROICexgc(3y)61.8%
ROICexgc(5y)75.33%
ROCE(3y)27.57%
ROCE(5y)31.69%
ROICexcg growth 3Y-24.2%
ROICexcg growth 5Y-22.07%
ROICexc growth 3Y-22.67%
ROICexc growth 5Y-19.19%
OM growth 3Y-13.39%
OM growth 5Y-8.6%
PM growth 3Y-14.27%
PM growth 5Y-8.18%
GM growth 3Y-0.31%
GM growth 5Y-0.56%
F-Score7
Asset Turnover1.28
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 115.79% | ||
| Cap/Sales | 1.81% | ||
| Interest Coverage | 583.92 | ||
| Cash Conversion | 84.83% | ||
| Profit Quality | 120.87% | ||
| Current Ratio | 3.93 | ||
| Quick Ratio | 3.37 | ||
| Altman-Z | 6.12 |
F-Score7
WACC9.25%
ROIC/WACC1.01
Cap/Depr(3y)112.9%
Cap/Depr(5y)112.37%
Cap/Sales(3y)1.45%
Cap/Sales(5y)1.45%
Profit Quality(3y)102.14%
Profit Quality(5y)106.5%
High Growth Momentum
Growth
EPS 1Y (TTM)-8.41%
EPS 3Y-17.42%
EPS 5Y-8.37%
EPS Q2Q%-5.08%
EPS Next Y-24.27%
EPS Next 2Y-12.36%
EPS Next 3Y-5.97%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.11%
Revenue growth 3Y-6.72%
Revenue growth 5Y-4.98%
Sales Q2Q%-6.16%
Revenue Next Year-6.86%
Revenue Next 2Y2.01%
Revenue Next 3Y3.88%
Revenue Next 5YN/A
EBIT growth 1Y-9.92%
EBIT growth 3Y-19.21%
EBIT growth 5Y-13.15%
EBIT Next Year18.7%
EBIT Next 3Y8.12%
EBIT Next 5YN/A
FCF growth 1Y-8.14%
FCF growth 3Y-27.16%
FCF growth 5Y-16.78%
OCF growth 1Y-7.99%
OCF growth 3Y-23.92%
OCF growth 5Y-14.22%